Government Shutdown Having Serious Impact on Health Care Agencies

Share this article:
Government Shutdown Impacting Health Care Agencies
Government Shutdown Impacting Health Care Agencies

(HealthDay News) -- The government shutdown is having a serious impact on health care agencies, according to an article published Oct. 1 in Medical Economics.

Due to the government shutdown, 52% of the Department of Health and Human Services (HHS) staff is being furloughed and several government-provided health care services are being affected.

HHS activities that are continuing relate to the safety of human life and protection of property and include specific programs within government agencies.

These include minimal support and staffing for the National Institutes of Health (NIH) ongoing protocols and safeguarding of facilities and infrastructure, as well as animal care services; minimal support at the Centers for Disease Control and Prevention, including reduced capacity to respond to outbreak investigation, and processing of laboratory samples; and limited activities related to user-fee-funded programs of the Food and Drug Administration, as well as vital activities such as consumer protection for emergencies, high-risk recalls, and other critical public health issues.

The NIH will not admit new patients, and the CDC will not support the influenza program; update disease treatment and prevention recommendations; or provide technical assistance, analysis, or support for infectious disease surveillance.

"Consistent with legal advice that activities authorized by law, including those that do not rely on annual appropriations, and activities that involve the safety of human life and protection of property are to be continued," according to the report.

Share this article:

Related Resources

You must be a registered member of Chemotherapy Advisor to post a comment.
close

Next Article in General Oncology News

Sign Up for Free e-newsletters

Enter Our April Contest

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in General Oncology News

The Future of Clinical Trials: 'Smaller and Smarter'

The Future of Clinical Trials: 'Smaller and Smarter'

The time has come to "raise the bar" in cancer clinical trials.

Cognitive Decline Inversely Linked to Cancer Mortality Risk

Cognitive Decline Inversely Linked to Cancer Mortality Risk

Elderly individuals who experience faster cognitive decline appear to be at reduced risk of dying from cancer.

CDC: Invasive Cancer Incidence Down from 2010

CDC: Invasive Cancer Incidence Down from 2010

Majority of states still have not reached 2020 targets for reduced cancer incidence.